-
Filamentous Phage for Therapeutic Applications in Non-Small Cell Lung Cancer and Brain Metastases: Recent Prospect
19 Jan 2026 18:47 GMT
… specifically binding to lung cancer tumors.
Principles of … the efficacy of gene therapies by combining targeting … in lung cancer patients or using transplanted lung cancer animal … and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol …
-
Advances in Nanomedicine-Mediated Photodynamic Therapy for Lung Cancer: Challenges and Perspectives
16 Jan 2026 14:58 GMT
… personalized nanotherapeutics for lung cancer treatment.
Emerging … photosensitizer.
PDT + Gene Therapy
Furthermore, gene therapy has also been … . Therefore, combining gene therapy and PDT also … in immunotherapy–resistant lung tumor. Int Immunopharmacol. …
-
Targeted Co-Delivery of Curcumin and Astragaloside IV via Hybrid Membrane-Coated Biomimetic Liposomes for Enhanced Lung Cancer Therapy
13 Jan 2026 15:25 GMT
… has demonstrated significant anti-lung cancer activity through various … cooperative inhibition of lung cancer cell proliferation. This … astragaloside IV inhibits lung cancer progression and metastasis by … targeted mRNA-based cancer gene therapy. ACS Nano. …
-
A Single-Cell Transcriptomic Atlas Elucidates a Microglial Gene Signature Linking Ferroptosis to Mitochondrial Dysfunction in Epilepsy
29 Jan 2026 12:41 GMT
… than specific pathogenic genes. Gene therapy represents a transformative therapeutic paradigm … in neutrophils, thereby accelerating lung cancer progression.51 By analogy, … Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5 …
-
Inflammation: The Pathological Axis of Cisplatin-Induced Renal Injury
29 Jan 2026 12:42 GMT
… cisplatin’s anticancer efficacy. Gene therapy represents a leading frontier … AKI. However, renal gene therapy faces challenges in delivery … outcomes. In summary, gene therapy, nano-drug delivery, … acute kidney injury in lung cancer. Inflamm Res. 2019 …
-
Biomarkers Market Size to Surpass USD 366.64 Billion by 2035 | Nova One Advisor
28 Jan 2026 14:42 GMT
… imminent commercial launch of its lung cancer assay.
More Insights Nova One … the complexities of cell and gene therapy, drug development, and the oncology …
-
Nipah Virus: India Says Only 2 Cases Confirmed As Fears Rise
28 Jan 2026 11:00 GMT
… Navy Veterans Mesothelioma & Lung Cancer Advocate Now Offers Direct Access … Shipyard Worker with Mesothelioma or Lung Cancer to Ensure a Top … Storm Season
Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector …
-
<![CDATA[Non-Viral Gene Therapy Displays Feasibility in EGFR-Mutated NSCLC]]>
25 Nov 2025 01:52 GMT
… innovative gene therapy that may benefit many [patients with] lung cancer, and … quaratusugene ozeplasmid gene therapy in patients with advanced NSCLC. Clin Lung Cancer. Published … phase 1 gene therapy clinical trial published in Clinical Lung Cancer. News …
-
USPTO grants patent to Genprex’s Reqorsa gene therapy
19 Nov 2025 10:43 GMT
… with extensive stage small cell lung cancer (ES-SCLC).
The trial is … clinical trial in small cell lung cancer.”
Genprex anticipates completing enrolment for … fast track designations.
Cell & Gene Therapy coverage on Pharmaceutical Technology is …
-
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
18 Nov 2025 12:28 GMT
… GNPX), a clinical-stage gene therapy company focused on developing … trial in small cell lung cancer," said Thomas Gallagher … further its pipeline of gene therapies in order to … lead product candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), is …